Pulmonary Hypertension

May 20, 2015November 5, 2015

Celsion’s Novel TheraSilence Technology Yields Positive Outcomes in Treating PH

This week, New Jersey based biopharmaceutical company Celsion, whose mission is the development of innovative, targeted therapies that address unmet medical needs in oncology, announced the publication of the abstract ... Read more

May 19, 2015November 5, 2015

Bayer Presents New Research on Pulmonary Arterial Hypertension and Chronic Thromboembolic Pulmonary Hypertension at 2015 ATS Annual Conference

News, Pulmonary Hypertension

During the 2015 Annual International Conference of the American Thoracic Society (ATS), Bayer HealthCare is presenting recent research on chronic thromboembolic pulmonary hypertension (CTEPH) and pulmonary arterial hypertension (PAH). The conference is taking ... Read more

May 19, 2015November 5, 2015

PHA Accepting Applications For Pulmonary Hypertension Research Funding

Pulmonary Hypertension

The Pulmonary Hypertension Association (PHA) has announced that the application period for the association’s first round of 2015 research awards is now open. This year marks 20 years of supporting research to address PH, with funding exceeding $15 ... Read more

May 18, 2015November 5, 2015

Insmed to Present on Rare Lung Disease Therapies at ATS Conference

News, Pulmonary Hypertension

Insmed Incorporated is presenting data on their therapies for rare pulmonary conditions at the American Thoracic Society‘s (ATS) 2015 International Conference, which is currently underway and will wrap up on May 20th in Denver. ... Read more

May 15, 2015November 5, 2015

Nurse Patricia Middings Wins Bayer’s Breathless Moments CTEPH Contest

News, Pulmonary Hypertension

Bayer recently announced the winner of Breathless Moments, a photography contest designed to raise awareness of chronic thromboembolic pulmonary hypertension (CTEPH) by showcasing sights, inspirational events or moments that can take someone’s breath ... Read more

May 15, 2015November 5, 2015

Actelion’s Encouraging Clinical Trial Results on PAH Therapies to be Presented at Upcoming Scientific Meeting

News, Pulmonary Hypertension

Actelion Pharmaceuticals Ltd recently announced in a press release that data from its Phase III trials on the drugs selexipag (Uptravi) and macitentan (Opsumit) will be presented at the upcoming ... Read more

May 13, 2015November 5, 2015

SteadyMed Submits Orphan Drug Designation Application For Experimental PAH Therapy Trevyent

News, Pulmonary Hypertension

San Ramon, California and Rehovot, Israel-based SteadyMed Ltd recently announced the submission of an Orphan Drug Designation application to the United States Food and Drug Administration (FDA) for Trevyent, its lead product to address pulmonary arterial ... Read more

May 8, 2015November 5, 2015

Bellerophon’s New Scientific Board to Focus on PH Device

News, Pulmonary Hypertension

Bellerophon Therapeutics, Inc. has established a new INOpulse Scientific Advisory Board (SAB) to help develop its proprietary novel technology to treat pulmonary hypertension (PH). The board includes internationally recognized specialists in the disease ... Read more

April 29, 2015November 5, 2015

Pulmonary Hypertension Association Marks World PH Day On May 5

News, Pulmonary Hypertension

On May 5, those that live with pulmonary hypertension (PH) and their families and loved ones are being asked to participate in a worldwide social media campaign to advocate for the fight against ... Read more

April 24, 2015November 5, 2015

RI Hospital Pulmonary Hypertension Center Receives Accreditation By PHA

Pulmonary Hypertension

The Pulmonary Hypertension Association (PHA) has awarded the Pulmonary Hypertension Center at Rhode Island Hospital through its accreditation program, making it one of the nation’s first centers of its kind ... Read more